BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28176203)

  • 1. Lipid profiles of donors and recipients of liver transplant: like father like son.
    Chu KKW; Chan SC; Sin SL; Chan ACY; Chok KSH; Cheng IKP; Lo CM
    Hepatol Int; 2017 May; 11(3):300-305. PubMed ID: 28176203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
    Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
    Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
    Jain A; Singhal A; Kashyap R; Safadjou S; Ryan CK; Orloff MS
    Transplantation; 2011 Aug; 92(4):453-60. PubMed ID: 21799468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
    Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients.
    Jain A; Venkataramanan R; Sharma R; Kwong T; Orloff M; Abt P; Kashyap R; Tsoulfas G; Batzold P; Williamson M; Bozorgzadeh A
    Transplantation; 2008 Feb; 85(4):554-60. PubMed ID: 18347534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic management of biliary complications after adult living-donor versus deceased-donor liver transplantation.
    Gómez CM; Dumonceau JM; Marcolongo M; de Santibañes E; Ciardullo M; Pekolj J; Palavecino M; Gadano A; Dávolos J
    Transplantation; 2009 Dec; 88(11):1280-5. PubMed ID: 19996927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of pharmacokinetics of mycophenolic acid and its metabolites between living donor liver transplant recipients and deceased donor liver transplant recipients.
    Shen B; Chen B; Zhang W; Mao H; Shen C; Deng X; Zhan X; Chen H
    Liver Transpl; 2009 Nov; 15(11):1473-80. PubMed ID: 19877254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: a systematic review and meta-analysis.
    Wan P; Yu X; Xia Q
    Liver Transpl; 2014 Apr; 20(4):425-36. PubMed ID: 24478109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation.
    Merion RM; Shearon TH; Berg CL; Everhart JE; Abecassis MM; Shaked A; Fisher RA; Trotter JF; Brown RS; Terrault NA; Hayashi PH; Hong JC;
    Ann Surg; 2010 Mar; 251(3):542-9. PubMed ID: 20130466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute kidney injury after orthotopic liver transplantation using living donor versus deceased donor grafts: A propensity score-matched analysis.
    Hilmi IA; Damian D; Al-Khafaji A; Sakai T; Donaldson J; Winger DG; Kellum JA
    Liver Transpl; 2015 Sep; 21(9):1179-85. PubMed ID: 25980614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].
    Liang DP; Yao XG; Li NF; Zhang DL; Guo YY; Lin L; Zhou L; Li WC; Yan ZT; Wang HM; Luo WL; Chang JH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 May; 45(5):440-3. PubMed ID: 21756789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation.
    Vagefi PA; Ascher NL; Freise CE; Dodge JL; Roberts JP
    Liver Transpl; 2012 Feb; 18(2):160-5. PubMed ID: 22006378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.
    Thuluvath PJ; Yoo HY
    Liver Transpl; 2004 Oct; 10(10):1263-8. PubMed ID: 15376301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
    Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
    Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.
    Fisher RA; Kulik LM; Freise CE; Lok AS; Shearon TH; Brown RS; Ghobrial RM; Fair JH; Olthoff KM; Kam I; Berg CL;
    Am J Transplant; 2007 Jun; 7(6):1601-8. PubMed ID: 17511683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
    Guo L; Orrego M; Rodriguez-Luna H; Balan V; Byrne T; Chopra K; Douglas DD; Harrison E; Moss A; Reddy KS; Williams JW; Rakela J; Mulligan D; Vargas HE
    Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does living donation have advantages over deceased donation in liver transplantation?
    Kaido T; Uemoto S
    J Gastroenterol Hepatol; 2010 Oct; 25(10):1598-603. PubMed ID: 20880167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study.
    Freise CE; Gillespie BW; Koffron AJ; Lok AS; Pruett TL; Emond JC; Fair JH; Fisher RA; Olthoff KM; Trotter JF; Ghobrial RM; Everhart JE;
    Am J Transplant; 2008 Dec; 8(12):2569-79. PubMed ID: 18976306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New onset dyslipidemia after renal transplantation: is there a difference between tacrolimus and cyclosporine?
    Deleuze S; Garrigue V; Delmas S; Chong G; Swarcz I; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2311-3. PubMed ID: 16980075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult dyslipidemia prediction is improved by repeated measurements in childhood and young adulthood. The Cardiovascular Risk in Young Finns Study.
    Nuotio J; Oikonen M; Magnussen CG; Viikari JS; Hutri-Kähönen N; Jula A; Thomson R; Sabin MA; Daniels SR; Raitakari OT; Juonala M
    Atherosclerosis; 2015 Apr; 239(2):350-7. PubMed ID: 25682034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.